Literature DB >> 230000

Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males.

K Berg, G Dahlén, A L Børresen.   

Abstract

In a study of 95 presumably healthy, 40-42-year old males from Northen Sweden, the Lp(a) phenotype distribution differed between those who had, and those who did not have one or more close relatives (parent or sib) with coronary heart disease. In the former group, 60% of the males were Lp(a+), as opposed to 28% in the latter group. Thus, in the homogeneous population sample studied, analysis of the normal inherited Lp(a) variation permitted the identification of distinct subpopulations, with respect to familial occurrence of coronary heart disease. None of a series of other parameters distinguished such sub-populations. The results reported are in agreement with our previous finding of a close association between phenotype Lp(a+) and risk of contracting coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230000     DOI: 10.1111/j.1399-0004.1979.tb01014.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

1.  A genome-wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population.

Authors:  Yibin Liu; Hongkun Ma; Qian Zhu; Bin Zhang; Hong Yan; Hanping Li; Jinxiu Meng; Weihua Lai; Liwen Li; Danqing Yu; Shilong Zhong
Journal:  J Lipid Res       Date:  2019-06-11       Impact factor: 5.922

Review 2.  Effects of exercise on lipoprotein(a).

Authors:  L T Mackinnon; L M Hubinger
Journal:  Sports Med       Date:  1999-07       Impact factor: 11.136

3.  Elevated lipoprotein(a) levels and homozygous human platelet antigen 1b (HPA-1b) genotype are risk factors for intrauterine growth restriction (IUGR).

Authors:  Andrea Gerhardt; Nadja Howe; Jan Steffen Krüssel; Ruediger Eberhard Scharf; Rainer Bernd Zotz
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

4.  Plasma lipids and lipoproteins and essential hypertension.

Authors:  M Flesch; A Sachinidis; Y D Ko; K Kraft; H Vetter
Journal:  Clin Investig       Date:  1994-12

5.  Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs.

Authors:  A S Dobs; M Prasad; A Goldberg; M Guccione; D R Hoover
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

Review 6.  Identifying genes for coronary artery disease: An idea whose time has come.

Authors:  Robert Roberts; Alexandre F R Stewart; George A Wells; Kathryn A Williams; Nihan Kavaslar; Ruth McPherson
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

Review 7.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

8.  Lipoprotein (a) concentrations as risk indicators for atherosclerosis.

Authors:  G M Kostner; A Czinner; K H Pfeiffer; M Bihari-Varga
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

9.  Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes.

Authors:  M A Austin; C Sandholzer; J V Selby; B Newman; R M Krauss; G Utermann
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.